Shaanxi Kanghui Pharmaceutical Co., Ltd.SSE: 603139

(603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 17th Meeting of the 6th Board of Directors

· Issued by Shaanxi Kanghui Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603139 · · 2 pages · Chinese

Summary by 6ix AI

The board approved several proposals, including increasing the comprehensive credit limit and providing guarantees for subsidiaries. They also approved an increase in the expected amount for daily related transactions for the upcoming year. Additionally, the board proposed to hold a temporary shareholders' meeting to discuss these matters further.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603139shaanxi-kanghui-pharmaceutical-co-ltdannouncement-on-resolutions-of-the-17th-meeting-of-the-6th-board-of-directors

Release

Announcement on Resolutions of the 17th Meeting of the 6th Board of Directors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shaanxi Kanghui Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Shaanxi Kanghui Pharmaceutical

All Shaanxi Kanghui Pharmaceutical news releases